Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
53,583,544
-
Total 13F shares
-
7,901,310
-
Share change
-
+6,861,392
-
Total reported value
-
$24,332,329
-
Price per share
-
$3.08
-
Number of holders
-
38
-
Value change
-
+$21,133,266
-
Number of buys
-
30
-
Number of sells
-
4
Institutional Holders of ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 per share (ABEO) as of Q4 2022
As of 31 Dec 2022,
ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 per share (ABEO) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,901,310 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., Point72 Asset Management, L.P., ARMISTICE CAPITAL, LLC, EcoR1 Capital, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), AIGH Capital Management LLC, VANGUARD GROUP INC, BARCLAYS PLC, GOLDMAN SACHS GROUP INC, and Worth Venture Partners, LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.